The acquisition bid follows in the footsteps of Calliditas recently winning FDA approval for Tarpeyo, its primary immunoglobulin A nephropathy (IgAN) treatment.
(Bloomberg) Australia’s largest pension fund plans to double its exposure to local lithium stocks over the next five years, after a price rout made producers of the key battery material more affordable.Most Read from BloombergBonds Slide as Fed’s Waller Downplays Need to Rush: Markets WrapMusk Pressures Tesla’s Board for Another Massive Stock AwardApple to Allow Outside Payments for Apps After US DecisionA Wary World Braces for Trump’s Return to the White HouseWhat Is Disease X? How Scientist
AustralianSuper to swoop on lithium stocks after price collapse miningweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miningweekly.com Daily Mail and Mail on Sunday newspapers.
AustralianSuper to Swoop on Lithium Stocks After Price Collapse bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
South Australia’s premier executive appointments column tracking the movements of those driving the state’s public and private sectors. Plus, the latest executive recruitment opportunities.